← Open Payments lookup

JAMIE STODD: Open Payments

NPI 1780011981 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$397 in 17 payments from 7 companies in 2025. Trend: 2023 $226 · 2024 $482 · 2025 $397

Food & beverage: $397
CompanyPaymentsAmount
Janssen Biotech, Inc.8$187
Amgen Inc.3$66
Regeneron Healthcare Solutions, Inc.2$41
Lilly USA, LLC1$30
Ortho Dermatologics, a division of Bausch Health US, LLC1$30
GENZYME CORPORATION1$26
Novartis Pharmaceuticals Corporation1$19

Products named: TREMFYA, DUPIXENT, OTEZLA, TALTZ, Cabtreo, COSENTYX.

Industry payments across MD — which companies pay providers there.